Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Dec 22, 2020- 88% of Americans say it's important for COVID-19 testing to work in support of vaccine rollout- Americans agree an authorized vaccine will not change the environment overnight, indicating a need for ongoing layered protections- Despite belief in effectiveness of vaccination and testing, there is concern that other precautionary measures will decline- Dec 17, 2020- Abbott's HeartMate 3™ heart pump approved for use for pediatric patients battling advanced heart failure- This life-saving technology provides new treatment option for underserved population
Dec 16, 2020- First at-home, virtually guided service to bring rapid, reliable and affordable testing into the home where the result is delivered in minutes- Abbott and eMed™ expect to deliver and administer 30 million BinaxNOW™ tests in the first quarter of 2021, with an additional 90 million in the second quarter- $25 cost for the test and service is the lowest available for at-home testing, which supports the home user to ensure a successful testing process- BinaxNOW is a highly portable, easy-to-use, 15-minute antigen test with no instrument that detects the virus when people are most infectious, which is critically important in slowing the spread of the virus- Service uses Abbott's complementary NAVICA™ app to enable the testing process and display authenticated BinaxNOW test results verified by a trained guide - and supports consumer confidence in testing at home- Dec 15, 2020- SARS-CoV-2 IgG II Quant antibody test measures levels of IgG antibodies to help measure and understand a person's immune response- The test specifically identifies levels of IgG antibodies that attach to the virus' spike protein which can be helpful to evaluate a person's immune response to vaccines- CE Mark test will be available for use on Abbott's ARCHITECT® and Alinity i™ platforms- Abbott plans to submit its test for U.S. Food and Drug Administration (FDA) emergency use authorization soon
- Dec 14, 2020- New product contains zinc, prebiotics and vitamins B12, C and E- Abbott expands its Pedialyte product portfolio with four new product introductions: Pedialyte with Immune Support, Pedialyte Sport, Pedialyte Organic and Pedialyte Electrolyte Water with Zero Sugar
- Dec 11, 2020- Increase reflects strength and sustainability of Abbott's diversified business- Dividend increased for 49th consecutive year- Abbott remains an S&P 500 Dividend Aristocrat
-
Dec 9, 2020Virtual reality training improved cath lab staff learning engagement by 45% and knowledge retention by 72%87% of studies show higher medical accuracy in medical practice by those trained with virtual reality
-
Dec 2, 2020- A survey, sponsored by Abbott, reveals three in four cardiologists worry the COVID-19 pandemic has restricted heart failure patients’ ability to manage their condition- In response to COVID-19, Abbott is partnering with physicians on tools and training programs to support the diagnosis and treatment of cardiovascular disease